XML 20 R26.htm IDEA: XBRL DOCUMENT

Note 14 - Segment and Geographic Information (Tables)

6 Months Ended

9 Months Ended

Jun. 30, 2013

Sep. 30, 2013

Schedule of Segment Reporting Information, by Segment [Table Text Block]

	Three Months Ended September 30,				Nine Months Ended September 30,
	2013		2012		2013		2012
Orthobiologics	$	12,830,566	$	9,242,783	$	40,620,339	$	30,262,991
Dermal		267,766		376,251		1,066,409		1,033,302
Surgical		1,136,248		1,426,273		3,955,134		3,874,405
Ophthalmic		1,425,609		1,891,433		2,818,407		8,515,160
Veterinary		1,363,157		1,118,700		3,124,953		2,865,187
Product revenue	$	17,023,346	$	14,055,440	$	51,585,242	$	46,551,045

ScheduleOfRevenueAndOperatingIncomeByGeographicalAreas

	Three Months Ended September 30,
	2013					2012
	Revenue		Percentage of Revenue			Revenue		Percentage of Revenue
Geographic Location:
United States	$	14,485,821		82	%	$	12,628,612		86	%
Europe		1,656,656		9	%		1,064,165		7	%
Other		1,611,961		9	%		1,073,834		7	%
Total revenue	$	17,754,438		100	%	$	14,766,611		100	%

	Nine Months Ended September 30,
	2013					2012
	Revenue		Percentage of Revenue			Revenue		Percentage of Revenue
Geographic Location:
United States	$	42,251,336		78	%	$	40,463,657		83	%
Europe		5,226,619		10	%		3,993,708		8	%
Other		6,351,871		12	%		4,294,675		9	%
Total revenue	$	53,829,826		100	%	$	48,752,040		100	%

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References+ Details